Epigenetics in human disease and prospects for epigenetic therapy

Gerda Egger(University of Southern California), Gangning Liang(Southern California University for Professional Studies), Ana M. Aparicio(University of Southern California), Peter A. Jones(University of Southern California)
Nature
May 1, 2004
10.1038/nature02625
Cited by 3,219

Abstract

Related Papers

The fundamental role of epigenetic events in cancer
Peter A. Jones, Stephen B. Baylin|Nature Reviews Genetics|2002|5.7k
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Ruthie E. Amir, Ignatia B. Van den Veyver, Mimi Wan et al.|Nature Genetics|1999|5k
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
Xinsheng Nan, Huck‐Hui Ng, Colin A. Johnson et al.|Nature|1998|3.4k
Cancer-epigenetics comes of age
P A Jones, Peter W. Laird|Nature Genetics|1999|2.4k
A gene hypermethylation profile of human cancer.
Manel Esteller, Paul G. Corn, Stephen B. Baylin et al.|PubMed|2001|2k